Document is current
Any future updates will be listed below
-
Authors
Xiao, Yuyao
Zheng, Xinde
Zhou, Changwu
Huang, Peng
Wu, Fei
Yang, Chun
Zeng, Mengsu https://orcid.org/0000-0002-2759-4844
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82171897)
Clinical Research Plan of SHDC (SHDC2020CR1029B)
Shanghai Municipal Key Clinical Specialty (shslczdzk03202)
Clinical Research Project of Zhongshan Hospital, Fudan University (2020ZSLC61)
- License Information
-
More Information
Article History
Received: 14 March 2022
Revised: 22 July 2022
Accepted: 29 August 2022
First Online: 16 September 2022
Declarations
:
: The scientific guarantor of this publication is Mengsu Zeng.
: The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.
: No complex statistical methods were necessary for this paper.
: Written informed consent was obtained from all patients in this study.
: Institutional Review Board approval was obtained.
: Some study subjects or cohorts have been previously reported in a prior study entitled “Combined hepatocellular carcinoma-cholangiocarcinoma: MRI features correlated with tumor biomarkers and prognosis” on <i>European Radiology</i>, “MR Features Based on LI-RADS Ver. 2018 Correlated with Cytokeratin 19 Expression in Combined Hepatocellular Carcinoma-Cholangiocarcinoma.” on <i>Journal of Hepatocellular Carcinoma</i>, and“Combined hepatocellular-cholangiocarcinoma: which preoperative clinical data and conventional MRI characteristics have value for the prediction of microvascular invasion and clinical significance?” on <i>European Radiology</i>.
: • retrospective• observational• performed at one institution
